EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Perturbation of the circadian clock in chronic diseases involving organ fibrosis

Atish Mukherji, Pierre-Louis Tharaux, David W Ray, Thomas F Baumert

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci194018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Atish Mukherji und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM), Inserm UMR_S1110, Strasbourg, France. Hauptthemen laut MEDLINE: Circadian Clocks, Renal Insufficiency, Chronic, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic organ disease is often complicated by fibrosis, the excessive accumulation of extracellular matrix, as a consequence of dysfunctional wound healing responses. Fibrosis progressively distorts tissue architecture and eventually leads to loss of organ function, accounting for up to 45% of deaths in developed countries. Moreover, fibrosis is a major risk factor for tumor development. The few approved therapies aimed at preventing or resolving fibrosis show limited efficacy and safety. One reason for the lack of efficient antifibrotic therapies is the fact that the cell circuits driving the disease biology are still only partially understood. The circadian clock is known to regulate the physiological functions of critical organs, including the liver, kidneys, and lungs. Several experimental and clinical studies have established that circadian disruption plays an important role in the development of chronic diseases across organs involving fibrosis. These include metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and chronic obstructive pulmonary disease. Here, we provide an overview of the circadian mechanisms that play critical roles in mediating physiological functions in the liver, kidneys, and lungs and whose deregulations could predispose toward development of chronic disease of these organs, leading to fibrosis. We also highlight the possible opportunities of chronotherapy for chronic diseases and discuss future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circadian ClocksRenal Insufficiency, ChronicPulmonary Disease, Chronic ObstructiveHumansFibrosisAnimalsChronic DiseaseLiver CirrhosisKidneyLungLiverFatty Liver

Autor:innen und Institutionen

  • University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM), Inserm UMR_S1110, Strasbourg, France.
  • Université Paris Cité, Inserm, Paris Cardiovascular Centre-PARCC, Paris, France.
  • National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
  • Oxford Centre for Diabetes, Endocrinology and Metabolism and.
  • Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.
  • Gastroenterology and Hepatology Service, Strasbourg University Hospitals, Strasbourg, France.

Zitieren

APA

Mukherji, A., Tharaux, P. L., Ray, D. W., & Baumert, T. F. (2025). Perturbation of the circadian clock in chronic diseases involving organ fibrosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci194018

Vancouver

Mukherji A, Tharaux PL, Ray DW, Baumert TF. Perturbation of the circadian clock in chronic diseases involving organ fibrosis. Journal of Clinical Investigation. 2025. doi:10.1172/jci194018

BibTeX
@article{Mukherji2025,
  author = {Mukherji, Atish and Tharaux, Pierre-Louis and Ray, David W and Baumert, Thomas F},
  title = {Perturbation of the circadian clock in chronic diseases involving organ fibrosis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci194018}
}
Kostenlos starten →